Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interpharm Holdings, Inc. was a generic pharmaceutical company based in Hauppauge, New York, that specialized in the development, manufacturing, and distribution of generic prescription and over-the-counter (OTC) medications. The company's product line focused on high-volume therapeutic areas such as pain management, cardiovascular health, and central nervous system disorders. Interpharm operated a state-of-the-art manufacturing facility and maintained relationships with major drug wholesalers and retail pharmacy chains across the United States. Despite its commercial presence, the company encountered significant regulatory hurdles and financial instability, eventually filing for Chapter 11 bankruptcy protection in 2008. Its assets were subsequently liquidated, and the company is no longer active in the pharmaceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interpharm Holdings.